Chi Sheng Pharma & Biotech Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 10, 2023 at 03:21 pm IST
Share
Chi Sheng Pharma & Biotech Co., Ltd reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 261.87 million compared to TWD 287.62 million a year ago. Net income was TWD 21.84 million compared to TWD 47.09 million a year ago. Basic earnings per share from continuing operations was TWD 0.38 compared to TWD 1.01 a year ago. Diluted earnings per share from continuing operations was TWD 0.38 compared to TWD 1.01 a year ago. Basic earnings per share was TWD 0.38 compared to TWD 0.83 a year ago. Diluted earnings per share was TWD 0.38 compared to TWD 0.82 a year ago.
For the nine months, sales was TWD 790.91 million compared to TWD 844.35 million a year ago. Net income was TWD 61.11 million compared to TWD 99.62 million a year ago. Basic earnings per share from continuing operations was TWD 1.07 compared to TWD 2.19 a year ago. Diluted earnings per share from continuing operations was TWD 1.07 compared to TWD 2.18 a year ago. Basic earnings per share was TWD 1.07 compared to TWD 1.75 a year ago. Diluted earnings per share was TWD 1.07 compared to TWD 1.74 a year ago.
Chi Sheng Pharma & Biotech Co., Ltd, formerly Chi Sheng Chemical Corporation is principally engaged in the manufacture and distribution of general medicines and medicinal injections. The Company provides injections, including hemodialysis concentrate, amino acid injection with electrolytes, vitamins, cephalosporin antibiotics, antihistamines and antipruritics, as well as ginkgo injections; oral preparations, including antibiotics, cold syrups and liquid antacid; external medicines, including contact lens fluid, normal saline for wash and povidone-iodine solution, and consumer goods, including functional health foods, skin care products and cosmetics. It also provides medical devices and equipment. The Company distributes its products in domestic markets and to overseas markets, including Mainland China and Southeast Asia.
CHI SHENG PHARMA & BIOTECH CO., LTD 
